Keyword
Quick search:
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Stem Cell Infusions Investigated for Treatment of COVID-19 ARDS
2 Endothelial tissue injury significantly contributes to ARDS in COVID-19 patients, finds study
3 Researchers receive $5.1 million to expand clinical trial of drug to prevent ARDS in COVID-19 patients
4 Umbilical Cord Stem Cells Show Promise as COVID-19 Therapy
5 Immunosuppressive Drugs for Autoimmune Disease May Reduce Risk of ARDS in COVID-19 Hospitalizations
6 DOD funding helps expand study of investigational drug to prevent ARDS in COVID
7 Acute Respiratory Distress Syndrome (ARDS) Epidemiology Forecast Report 2017-2030: Focus on United States, Germany, France, Italy, and United Kingdom, and Japan
8 Global Acute Respiratory Distress Syndrome (ARDS) Epidemiology Forecast to 2030
9 Mesoblast Update on COVID-19 ARDS Trial Australian Stock Exchange:MSB.AX
10 SARS-CoV-2 infection demonstrated in a human lung bronchioalveolar tissue model
11 Pluristem Enters Collaboration With Pharmaceutical Company Innovare R&D to Expand Pluristem's ARDS Associated With COVID-19 Program to Mexico
12 Researchers receive DOD funding to expand study of investigational drug to prevent ARDS in COVID-19 patients
13 Unique inflammatory profile is associated with higher SARS-CoV-2 acute respiratory distress syndrome (ARDS) mortality
14 Host-Viral Interactions Revealed among Shared Transcriptomics Signatures of ARDS and Thrombosis: A Clue into COVID-19 Pathogenesis
15 Tetra Bio-Pharma poised to receive government funding to help develop potential coronavirus treatment ARDS-003
16 SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage
17 Cerecor Announces Successful Proof of Concept Data for CERC-002, a Unique LIGHT-Neutralizing Antibody, in Patients Hospitalized with COVID-19 ARDS
18 Acticor Biotech Announces the Recruitment of the First Patient in its Phase 2 GARDEN Study in COVID-19_related ARDS
19 Ards chairman says it's 'time to void' Championship season as league still waiting for big kick-off
20 Complement Inhibition in Severe COVID-19 Acute Respiratory Distress Syndrome
21 First person enrolled in US study to assess efficacy of siltuximab as COVID-19 therapy
22 Even if it looks like COVID-19, think again: the importance of differential diagnosis during a pandemic
23 CohBar, NIAID to assess CB5064 Analogs for Covid-19 treatment
24 Functional Pathophysiology of SARS-CoV-2 Induced Acute Lung Injury and Clinical Implications
25 Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial
26 Food, sewing drive benefits ARDS
27 Assessing the importance of interleukin-6 in COVID-19
28 Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications
29 Mechanical circulatory support—Challenges, strategies, and preparations
30 Gran wedding for Ards man after pandemic upsets plans
31 Possible therapeutic interventions in COVID-19 induced ARDS by cotinine as an ACE-2 promoter and AT-1R blocker
32 Cedars-Sinai Study Finds Immune Flaws in COVID-19 Patients
33 Global Acute Respiratory Distress Syndrome (ARDS) Market: Recent Trends, Technology Updates and Top players covered, Faron Pharmaceuticals, Altor Bioscience, Athersys, GlaxoSmithKline, Mondobiotech, BioMarck Pharmaceuticals
34 Pressure‐induced alopecia due to proning in COVID‐19
35 EUSA Pharma Announces First Patient Enrolled in a Randomised Phase 3 Clinical Trial Investigating Siltuximab in Hospitalised Patients with COVID-19- or Another Respiratory Virus Infection-Associated Acute Respiratory Distress Syndrome (ARDS)
36 Windtree Announces First Patient Dosed in its Phase 2 Clinical Trial Studying KL4 Surfactant in Acute Lung Injury in Adults with COVID-19
37 Mesoblast's stem cell therapy fails to meet primary endpoint in COVID-19 study
38 CohBar Announces Preclinical Collaboration with NIAID to Evaluate Potential of CB5064 Analogs for Treatment of COVID-19 ARDS
39 Why a small Peninsula biotech thinks it can make a quick difference against Covid
40 Protecting lungs from ventilator-induced injury
41 Certain pot extracts might help prevent COVID-19-related respiratory distress: Lethbridge researchers
42 Prone during pandemic: development and implementation of a quality-based protocol for proning severe COVID-19 hypoxic lung failure patients in situationally or historically low resource hospitals
43 Ard's Chef Drew Ready For “Hell's Kitchen' Debut Tonight |
44 South Florida Doctors Make Medical Breakthrough In Treating Severe Cases Of COVID
45 Prone positioning improves oxygenation and lung recruitment in patients with SARS-CoV-2 acute respiratory distress syndrome; a single centre cohort study of 20 consecutive patients
46 COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?
47 Diagnosing ARDS Earlier and the Development of ICU Delirium in Patients With ARDS
48 Management of ARDS due to COVID-19 infection
49 Circulating cardiovascular microRNAs in critically ill COVID‐19 patients Short title: microRNA signatures in COVID‐19
50 Patients with ARDS, COVID-19 Face Significant Financial Effects in Recovery
51 Some severe cases of coronavirus could result in brain damage, inability to walk
52 Jubilant Therapeutics Announces Research Collaboration with The Wistar Institute to Evaluate the Activity of Novel PAD4 Inhibitors to Reduce Clinical Severity of COVID-19
53 Pathophysiology of COVID-19-associated acute respiratory distress syndrome
54 Omega Therapeutics Announces the Industry's First Programmable Epigenetic Medicine in Development and 2021 Priorities
55 What is Acute Respiratory Distress Syndrome (ARDS)?
56 Study Undercuts ARDS 'Phenotypes' in COVID-19
57 Nature and dimensions of the systemic hyper-inflammation and its attenuation by convalescent plasma in severe COVID-19
58 Global Acute Respiratory Distress Syndrome (ARDS) Market Insight, Epidemiology and Market Forecast to 2030
59 Derry/Strabane COVID-19 rate back to pre-Christmas level and lower than anywhere bar Ards and North Down
60 Treatment for severe acute respiratory distress syndrome from COVID-19
61 Edesa Biotech Expands COVID-19 Clinical Study to Colombia
62 COVID-19 pneumonia and pneumothorax: case series
63 Study identifies factors associated with ARDS in COVID-19
64 FDA grants Fast Track designation to COVID-19 ARDS treatment
65 Covid-19, Angiogenesis, and ARDS Endotypes | NEJM
66 Evaluation of PEEP and prone positioning in early COVID-19 ARDS
67 Coronavirus survivors can be left with lung damage, UK specialists say
68 The U.S. paid a Texas company nearly $70 million for ventilators that were unfit for covid-19 patients. Why?
69 ARDS treatments are important for severe Covid-19
70 Study finds link between low fungi diversity in lungs and severity of ARDS
71 Patients with ARDS, preexisting psychiatric illness more likely to develop ICU delirium
72 Effect of PEEP in COVID-19-Related ARDS Similar to Classical ARDS
73 685 new coronavirus cases in district; 7 succumb to infection
74 Fewer fungi types in lungs associated with more severe ARDS
75 RedHill's Phase 2/3 COVID-19 Candidate Opaganib Reduces ARDS-Related Blood Clotting in Preclinical Model
76 The pathogenesis of microthrombi in COVID cannot be controlled by DOAC: NETosis should be the target
77 Councillor sparks debate with 'quieter' fireworks call
78 RedHill's P2/3 COVID-19 candidate Opaganib reduces ARDS-related blood clotting
79 Why You Shouldn't Treat COVID-19 ARDS Like HAPE
80 Novartis Inks $1.35 Billion Deal with Mesoblast for Remestemcel-L for COVID-19 ARDS
81 CohBar Confirms Efficacy of Novel Apelin Agonists in Acute Respiratory Distress Syndrome (ARDS) Model
82 Bioactive lipids in antiviral immunity
83 Acute respiratory failure mortality increases in United States and may worsen with COVID-19 pandemic
84 Marijuana Compound Could Help Acute Respiratory Distress Syndrome
85 Remestemcel-L Fast Tracked for ARDS Due to COVID-19
86 Pragmatic Recommendations for the Prevention and Treatment of Acute Kidney Injury in Patients with COVID-19 in Low- and Middle-Income Countries
87 Derry/Strabane COVID-19 rate falls again
88 Acute Respiratory Distress Syndrome Mortality Based on Arterial CO2 Management
89 Altered gut microbial metabolites could mediate the effects of risk factors in Covid‐19
90 Best practices for mechanical ventilation in patients with ARDS, COVID-19
91 Facial Pressure Injuries from Prone Positioning in the COVID‐19 Era
92 Citius Pharmaceuticals Subsidiary NoveCite Announces Data from a Study of Induced Mesenchymal Stem Cell ("i-MSC") Therapy in an in vivo Model of Acute Respiratory Distress Syndrome ("ARDS")
93 Development of toxic epidermal necrolysis in a coronavirus disease 2019 patient with recurrence of positive SARS‐CoV‐2 viral RNA
94 COVID-19 Pneumonia: Only Some Cases Are Like Severe ARDS
95 Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: Cross-sectional analysis from a diverse US metropolitan area
96 Fast Five Quiz: Acute Respiratory Distress Syndrome (ARDS)
97 COVID-19 and ARDS Educational Webinar: Recovery and Life After the ICU
98 ARDS may not be the primary lung iInjury in COVID-19
99 Should Steroids Be Used to Treat ARDS?
100 How Acute Respiratory Distress Syndrome (ARDS) May Be Affecting COVID-19 Patients